Showing results (951-960 of 2,564) with videos related to
Sort By:
Pageof 257
Drug Testing and Analysis|August 5, 2017
Determination of GnRH and its synthetic analogues' abuse in doping control: Small bioactive peptide UPLC-MS/MS method extension by addition of in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameter fluctuations as suitable biomarkersIrina Zvereva, Grigory Dudko, Marina DikunetsDrug Testing and Analysis|September 19, 2015
Simultaneous determination of tanshinones and polyphenolics in rat plasma by UPLC-MS/MS and its application to the pharmacokinetic interaction between themHao Ren, Dawei Qian, Shulan Su, et al.Drug Testing and Analysis|November 24, 2015
Olodaterol and vilanterol detection in sport drug testingZdenek Chundela, Joachim GroßeDrug Testing and Analysis|November 24, 2015
The history of efforts to regulate dietary supplements in the USAJohn P SwannDrug Testing and Analysis|November 24, 2015
Should states and local governments regulate dietary supplements?Ranjani StarrDrug Testing and Analysis|November 18, 2017
Evaluation of markers out of the steroid profile for the screening of testosterone misuse. Part I: Transdermal administrationAristotelis Kotronoulas, Àlex Gomez-Gómez, Andreu Fabregat, et al.Drug Testing and Analysis|November 18, 2017
Development and validation of an ultrahigh performance liquid chromatography-high resolution tandem mass spectrometry quantification method for hypoglycin A and methylene cyclopropyl acetic acid carnitine in horse serum in cases of atypical myopathyWiebke Rudolph, Daniela Remane, Dirk K Wissenbach, et al.Drug Testing and Analysis|November 21, 2017
Elimination profile of triamcinolone in urine following oral administrationTing-Ting Chen, Yi-Chun Tseng, Tai-Yuan Huang, et al.Drug Testing and Analysis|December 2, 2017
Detection of Sotatercept (ACE-011) in human serum by SAR-PAGE and western single blottingChristian Reichel, Letizia Farmer, Günter Gmeiner, et al.Drug Testing and Analysis|September 9, 2017
In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICASandra N Staeheli, Michael Poetzsch, Veronica P Veloso, et al.Pageof 257